Article de revue
From epidemic meningitis vaccines for Africa to the Meningitis Vaccine Project
In June 2001, BMGF awarded a grant of US$70 million to create the Meningitis Vaccine Project (MVP) as a partnership between PATH and WHO, with the specific goal of developing an affordable MenA conjugate vaccine to eliminate MenA meningitis epidemics in Africa. EVA is an example of the use of WHO as an important convening instrument to facilitate new approaches to address major public health problems.
Auteurs
Langues
- Anglais
Année de publication
2015
Journal
Clin Infect Dis.
Volume
Suppl. 5
Type
Article de revue
Catégories
- Initiatives mondiales
Pays
- Bénin
- Burkina Faso
- Burundi
- Cameroun
- République centrafricaine
- Tchad
- Côte d'Ivoire
- République démocratique du Congo
- Érythrée
- Éthiopie
- Ghana
- Guinée
- Guinée-Bissau
- Kenya
- Mali
- Mauritanie
- Niger
- Nigéria
- Rwanda
- Sénégal
- Soudan du Sud
- Togo
- Ouganda
Régions de l'OMS
- Région africaine
